Defitelio

About Jazz Pharmaceuticals

Jazz Pharmaceuticals (NASDAQ: JAZZ) is a Dublin-based global biopharmaceutical company focused on transforming the lives of patients with rare diseases through innovative therapeutics. With a proven track record in developing and commercializing treatments for rare epilepsies, oncology, and sleep disorders, the company operates across nearly 100 countries with manufacturing facilities in the U.S., U.K., Ireland, and throughout Europe. Led by President and CEO Renee Gala, Jazz combines a patient-focused approach with science-driven research to advance a robust pipeline of innovative therapeutics targeting unmet medical needs.

Therapeutic Areas